Literature DB >> 28789347

Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.

Zhiliang He1,2, Youjia Yu1,3, Yunhong Nong1,2, Lingyao Du1,2, Cong Liu1,2, Yong Cao1,3, Lang Bai1,2, Hong Tang1,2.   

Abstract

Hepatitis B virus X protein (HBx), a multifunctional protein encoded by the X gene of the hepatitis B virus (HBV) is involved in the metastasis of HBV-associated hepatocellular carcinoma (HCC) through various pathways, including upregulating intracellular reactive oxygen species (ROS). Thioredoxin interacting protein (TXNIP) is a key mediator of intracellular ROS, but its function in HBx-mediated metastasis of HBV-associated HCC is elusive. In the present study, HBV-associated HCC tissues with or without metastasis and HepG2 cells were used to study the function of TXNIP in HBx-mediated metastasis of HBV-associated HCC. Initially, the expression levels of TXNIP and HBx in HBV-associated HCC tissues were detected by immunohistochemistry and reverse transcription-quantitative polymerase chain reaction. The results revealed that high expression of TXNIP may be an independent risk factor for metastasis of HBV-associated HCC, and the mRNA levels of TXNIP and HBx were positively associated. Secondly, the association between HBx and TXNIP was investigated using a HBx expression stable cell line, in which HBx expression was induced and controlled by doxycycline. The results demonstrated that HBx may upregulate TXNIP expression in HepG2 cells. Thirdly, the effects of TXNIP and HBx on HepG2 cell migration and invasion were studied by scratch and Matrigel invasion assays, respectively. The results demonstrated that TXNIP overexpression enhanced HepG2 cell migration and invasion. In addition, ectopic expression of HBx promoted HepG2 cell migration and invasion, and this effect may be attenuated by knockdown of TXNIP expression, which indicated that TXNIP may be involved in the process. In summary, the present results demonstrated that TXNIP may be involved in HBx-mediated metastasis of HBV-associated HCC.

Entities:  

Keywords:  hepatitis B virus X protein; hepatocellular carcinoma; metastasis; thioredoxin interacting protein

Year:  2017        PMID: 28789347      PMCID: PMC5529791          DOI: 10.3892/ol.2017.6296

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  58 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.

Authors:  Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; T Jake Liang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  HBx-dependent activation of Twist mediates STAT3 control of epithelium-mesenchymal transition of liver cells.

Authors:  Jing Teng; Xiaoqian Wang; Zhenxing Xu; Nanhong Tang
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

5.  The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication.

Authors:  Hong Tang; Luvsanjav Delgermaa; Feijun Huang; Naoki Oishi; Li Liu; Fang He; Liansan Zhao; Seishi Murakami
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 6.  The role of hepatitis B virus X protein is related to its differential intracellular localization.

Authors:  Jingwei Ma; Tucheng Sun; Sujin Park; Guanxin Shen; Junwei Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-06-21       Impact factor: 3.848

Review 7.  Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine.

Authors:  Soo Hyung Ryu; Myoung Kuk Jang; Woo Jean Kim; Danbi Lee; Young-Hwa Chung
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

8.  Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

Authors:  Venkata Ramesh Dasari; Kiranpreet Kaur; Kiran Kumar Velpula; Meena Gujrati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 9.  Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  Mirko Tarocchi; Simone Polvani; Giada Marroncini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 10.  Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Authors:  Eiji Yoshihara; So Masaki; Yoshiyuki Matsuo; Zhe Chen; Hai Tian; Junji Yodoi
Journal:  Front Immunol       Date:  2014-01-09       Impact factor: 7.561

View more
  7 in total

1.  Transcriptomic analysis of cells in response to EV71 infection and 2Apro as a trigger for apoptosis via TXNIP gene.

Authors:  Chenguang Yao; Kanghong Hu; Caili Xi; Ni Li; Yanhong Wei
Journal:  Genes Genomics       Date:  2018-11-29       Impact factor: 1.839

2.  Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma.

Authors:  Aysim Gunes; Ezgi Bagirsakci; Evin Iscan; Gulcin Cakan-Akdogan; Umut Aykutlu; Serif Senturk; Gunes Ozhan; Esra Erdal; Deniz Nart; Funda Yilmaz Barbet; Nese Atabey
Journal:  Oncotarget       Date:  2018-12-07

3.  Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis.

Authors:  Ryan Douglas Estep; Aparna N Govindan; Minsha Manoharan; He Li; Suzanne S Fei; Byung S Park; Michael K Axthelm; Scott W Wong
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

4.  C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.

Authors:  Yu Zhang; Qian Yan; Lanqi Gong; Hang Xu; Beilei Liu; Xiaona Fang; Dandan Yu; Lei Li; Ting Wei; Ying Wang; Ching Ngar Wong; Zhaojie Lyu; Ying Tang; Pak Chung Sham; Xin-Yuan Guan
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

Review 5.  TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook.

Authors:  Min Pan; Fengping Zhang; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

Review 6.  The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.

Authors:  Eckhard Klieser; Christian Mayr; Tobias Kiesslich; Till Wissniowski; Pietro Di Fazio; Daniel Neureiter; Matthias Ocker
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

Review 7.  Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers.

Authors:  Yiting Chen; Jieling Ning; Wenjie Cao; Shuanglian Wang; Tao Du; Jiahui Jiang; Xueping Feng; Bin Zhang
Journal:  Front Oncol       Date:  2020-10-21       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.